[Paediatric pseudophakia - refractive changes after primary and secondary intraocular lens implantation]

I Ryseck1, B Wahl, T Lischka

  • 1Augenklinik/Ple- und Orthoptik, Universitätsklinikum Hamburg-Eppendorf, Hamburg. iryseck@uke.uni-hamburg.de

Klinische Monatsblatter Fur Augenheilkunde
|April 8, 2011
PubMed

Insights

Predicting myopic shift after intraocular lens (IOL) implantation in children remains challenging. This study found no significant difference in refractive changes between primary and secondary IOL implantations, with the lowest shift observed in the youngest children.

Area of Science:

  • Ophthalmology
  • Pediatric ophthalmology
  • Refractive surgery

Context:

  • Children undergoing cataract extraction and intraocular lens (IOL) implantation can experience a myopic shift.
  • The extent of this refractive change is difficult to predict accurately.
  • This study investigates refractive development in pseudophakic children following both primary and secondary IOL implantation.

Purpose:

  • To report and analyze the refractive development in pseudophakic children after primary and secondary IOL implantation.
  • To compare refractive changes between primary and secondary IOL implantations across different age groups.
  • To assess the predictability of myopic shift in pediatric patients.

Summary:

  • A retrospective review of 62 eyes from 41 patients (aged 3-12 years) who received IOL implantation between 2000 and 2008 was conducted.
  • The mean myopic shift was 2.5 D overall, with no significant difference between primary and secondary IOL implantations.
  • The lowest myopic shift was observed in the youngest age group (3-4 years), contrary to some existing literature.

Impact:

  • Findings suggest that primary and secondary IOL implantations result in similar refractive changes in children.
  • The study highlights the difficulty in precisely predicting myopic shift after pediatric IOL surgery.
  • Results provide valuable data for ophthalmologists managing pediatric pseudophakia and counseling families on visual outcomes.
Abstract

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...